Atlas Venture Associates XI, L.P.'s Net Worth
Estimate Recalculated Jun 18, 2025 08:57PM EST
Who is Atlas Venture Associates XI, L.P.
Atlas Venture Associates XI, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., Akero Therapeutics, Inc., Ikena Oncology, Inc., Xilio Therapeutics, Inc., Day One Biopharmaceuticals, Inc., Third Harmonic Bio, Inc., and Korro Bio, Inc..
SEC CIK
Atlas Venture Associates XI, L.P.'s CIK is 0001780068
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
